Description
Tirzepatide is a dual GLP-1 and GIP receptor agonist studied extensively for metabolic health research. Active compound in FDA-approved Mounjaro® and Zepbound®.
Research Applications
- Type 2 diabetes and insulin resistance research
- Weight management and metabolic syndrome studies
- Cardiovascular health research
- Non-alcoholic fatty liver disease (NAFLD) research
Product Specifications
- Purity: 99%+ (HPLC verified)
- Form: Lyophilized powder
- Storage: 2-8°C; freeze for extended storage
For research and laboratory use only. Not intended for human or animal consumption.





Reviews
There are no reviews yet.